
| ASSET | DATE | % RETURN |
|---|---|---|
DeFi Technologies (DEFT) | 9/4/2016 - 10/12/2016 | 3,915% |
XMax (XWIN) | 9/4/2016 - 10/12/2016 | 236% |
Alpha Metallurgical Resources (AMR) | 9/4/2016 - 10/12/2016 | 165.22% |
Cronos (CRON) | 9/4/2016 - 10/12/2016 | 143.27% |
Matinas BioPharma (MTNB) | 9/4/2016 - 10/12/2016 | 135.44% |
Corbus Pharmaceuticals (CRBP) | 9/4/2016 - 10/12/2016 | 123.53% |
Datasea (DTSS) | 9/4/2016 - 10/12/2016 | 122.22% |
Aurora Cannabis (ACB) | 9/4/2016 - 10/12/2016 | 112.44% |
Aurinia Pharmaceuticals (AUPH) | 9/4/2016 - 10/12/2016 | 108.78% |
Collegium Pharmaceutical (COLL) | 9/4/2016 - 10/12/2016 | 102.34% |
OLB (OLB) | 9/4/2016 - 10/12/2016 | 100% |
Sarepta Therapeutics (SRPT) | 9/4/2016 - 10/12/2016 | 97.97% |
InMed Pharmaceuticals (INM) | 9/4/2016 - 10/12/2016 | 97.37% |
Merus (MRUS) | 9/4/2016 - 10/12/2016 | 83.85% |
Bone Biologics (BBLG) | 9/4/2016 - 10/12/2016 | 80% |
Assembly Biosciences (ASMB) | 9/4/2016 - 10/12/2016 | 79.9% |
Protagonist Therapeutics (PTGX) | 9/4/2016 - 10/12/2016 | 78.35% |
Curis (CRIS) | 9/4/2016 - 10/12/2016 | 77.19% |
Bank of NT Butterfield & Son (NTB) | 9/4/2016 - 10/12/2016 | 73.69% |
Ainos (AIMD) | 9/4/2016 - 10/12/2016 | 73.61% |
PTC Therapeutics (PTCT) | 9/4/2016 - 10/12/2016 | 68.89% |
Eledon Pharmaceuticals (ELDN) | 9/4/2016 - 10/12/2016 | 67.76% |
Sobr Safe (SOBR) | 9/4/2016 - 10/12/2016 | 66.67% |
CEA Industries (BNC) | 9/4/2016 - 10/12/2016 | 61.86% |
Ekso Bionics (EKSO) | 9/4/2016 - 10/12/2016 | 58.82% |